Ching‐Chu Chen

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan

Ching‐Chu Chen, Tsai‐Chung Li, Pei-Chia Chang et al. · Metabolism · 2008 · 142 citations

Obesity, Metabolic Syndrome, Tobacco Control +8

Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan

Shih‐Wei Lai, Kuan‐Fu Liao, Pei‐Chun Chen et al. · Clinical Lung Cancer · 2011 · 138 citations

Oncology, Medicine, Global Health +9

Association between television viewing and the risk of metabolic syndrome in a community-based population

Pei-Chia Chang, Tsai‐Chung Li, Ming‐Tsang Wu et al. · BMC Public Health · 2008 · 77 citations · Full text